All month long Missouri Partnership is taking a look back at some of Missouri’s biggest stories in economic development from the past year, and today we are taking a look back at Aptimmune Biologics’ headquarters relocation to St. Louis, Missouri.
In January, Aptimmune Biologics, an animal health company that specializes in creating swine vaccines, relocated its headquarters and laboratory to the Bio-Research & Development Growth Park in St. Louis, Missouri’s 39 North innovation district. The company says the move was “due in large part to the exceptional financial and logistics support the company has received from investors and other businesses in the St. Louis area.”
“Aptimmune represents the type of fast growing, next generation animal health company that Missouri is excited to support,” said Bill Anderson, Executive Director of Missouri Technology Corp., which helped invest in Aptimmune. “Their decision to relocate to the 39 North innovation district is further proof of Missouri’s strength as a growing hub of agtech innovation.”
Check out our full coverage here.
For more information on why Missouri could be a prime location to launch or grow your business, contact Steve Johnson, CEO of Missouri Partnership, at 314.725.2688 or via our contact form, with any questions you might have, and learn how Missouri Partnership can help with your business expansion needs.